Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Psychiatry
Published in: BMC Psychiatry 1/2021

01-12-2021 | Mood Disorders | Research article

Psychometric properties of the Norwegian version of the Patient Health Questionnaire-9 (PHQ-9) in a large female sample of adults with and without eating disorders

Authors: Line Wisting, Sverre Urnes Johnson, Cynthia M. Bulik, Ole A. Andreassen, Øyvind Rø, Lasse Bang

Published in: BMC Psychiatry | Issue 1/2021

Login to get access

Abstract

Background

Internationally, the Patient Health Questionnaire-9 (PHQ-9) is commonly used to assess the frequency and severity of depressive symptoms. However, psychometric properties of the Norwegian version of the PHQ-9 have only been assessed in adolescents. We present normative data for women and an evaluation of the psychometric properties (internal consistency, convergent validity, and factor structure) of the Norwegian PHQ-9 among women with and without eating disorders (ED).

Methods

In this case-control study, a total of 793 females aged 18–78 years (mean 30.39; SD 9.83) completed an online self-report assessment. Measures included the ED100K and Eating Disorder Examination Questionnaire (EDE-Q) to assess ED psychopathology, and the Generalized Anxiety Disorder (GAD) scale and Difficulties in Emotion Regulation Scale Short Form (DERS-SF) to assess symptoms of anxiety and emotion regulation deficits. Participants were categorized into three groups, i.e., previous ED (19.7%, n = 148), current ED (36.3%, n = 272), and no history of ED (44.0%, n = 330), based on self-reported scores on the ED 100 K and the EDE-Q.

Results

Mean PHQ-9 total score for those with a previous history of ED was 10.67 (SD 6.33), for those with a current ED 16.61 (SD 5.84), and for those with no lifetime history of ED 6.83 (SD 5.58). Excellent internal consistency was demonstrated by Cronbach’s alpha’s for individuals with a previous ED (.88), for individuals with a current ED (.86), and for individuals with no history of ED (.88). Acceptable convergent validity was indicated based on significant correlations between the PHQ-9 and GAD-7 and DERS-SF. Confirmatory Factor Analyses revealed a mediocre fit for a one-factor structure of the PHQ-9, regardless of diagnostic status.

Conclusions

The psychometric properties of the Norwegian version of the PHQ-9 are acceptable across females with and without ED, and the PHQ-9 can be recommended for use in clinical ED settings and for people without mental disorders.
Appendix
Available only for authorised users
Literature
1.
American Psychiatric Association. The Diagnostic and Statistical Manual of Mental Disorders: DSM-5. 5th Edition ed. Washington DC: American Psychiatric Association; 2013.CrossRef
2.
Visted E, Vøllestad J, Nielsen MB, Schanche E. Emotion regulation in current and remitted depression: a systematic review and meta-analysis. Front Psychol. 2018;9:756.PubMedPubMedCentralCrossRef
3.
Neuendorf R, Harding A, Stello N, Hanes D, Wahbeh H. Depression and anxiety in patients with inflammatory bowel disease: a systematic review. J Psychosom Res. 2016;87:70–80.PubMedCrossRef
4.
Wisting L, Skrivarhaug T, Dahl-Jørgensen K, Rø Ø. Prevalence of disturbed eating behavior and associated symptoms of anxiety and depression among adult males and females with type 1 diabetes. J Eat Disord. 2018;6(1):28.PubMedPubMedCentralCrossRef
5.
Cohen BE, Edmondson D, Kronish IM. State of the art review: depression, stress, anxiety, and cardiovascular disease. Am J Hypertens. 2015;28(11):1295–302.PubMedPubMedCentralCrossRef
6.
Koo J, Marangell LB, Nakamura M, Armstrong A, Jeon C, Bhutani T, et al. Depression and suicidality in psoriasis: review of the literature including the cytokine theory of depression. J Eur Acad Dermatol Venereol. 2017;31(12):1999–2009.PubMedCrossRef
7.
Groenman AP, Janssen TWP, Oosterlaan J. Childhood psychiatric disorders as risk factor for subsequent substance abuse: a meta-analysis. J Am Acad Child Adolesc Psychiatry. 2017;56(7):556–69.PubMedCrossRef
8.
Johnson D, Dupuis G, Piche J, Clayborne Z, Colman I. Adult mental health outcomes of adolescent depression: a systematic review. Depress Anxiety. 2018;35(8):700–16.PubMedCrossRef
9.
Puccio F, Fuller-Tyszkiewicz M, Ong D, Krug I. A systematic review and meta-analysis on the longitudinal relationship between eating pathology and depression. Int J Eat Disord. 2016;49(5):439–54.PubMedCrossRef
10.
Levis B, Yan XW, He C, Sun Y, Benedetti A, Thombs BD. Comparison of depression prevalence estimates in meta-analyses based on screening tools and rating scales versus diagnostic interviews: a meta-research review. BMC Med. 2019;17(1):65.PubMedPubMedCentralCrossRef
11.
Godart N, Radon L, Curt F, Duclos J, Perdereau F, Lang F, et al. Mood disorders in eating disorder patients: prevalence and chronology of ONSET. J Affect Disord. 2015;185:115–22.PubMedCrossRef
12.
Godart NT, Perdereau F, Rein Z, Berthoz S, Wallier J, Jeammet P, et al. Comorbidity studies of eating disorders and mood disorders. Critical review of the literature. J Affect Disord. 2007;97(1–3):37–49.PubMedCrossRef
13.
Ferrari AJ, Charlson FJ, Norman RE, Patten SB, Freedman G, Murray CJ, et al. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med. 2013;10(11).
14.
Friedrich MJ. Depression is the leading cause of disability around the world. Jama. 2017;317(15):1517.PubMed
15.
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.PubMedCrossRef
16.
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. ArchGenPsychiatry. 1961;4:561–71.
17.
18.
Pettersson A, Bostrom KB, Gustavsson P, Ekselius L. Which instruments to support diagnosis of depression have sufficient accuracy? A systematic review. Nordic J Psychiatry. 2015;69(7):497–508.CrossRef
19.
Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary care evaluation of mental disorders. Patient health questionnaire. Jama. 1999;282(18):1737–44.PubMedCrossRef
20.
Spitzer RL, Williams JB, Kroenke K, Hornyak R, McMurray J. Validity and utility of the PRIME-MD patient health questionnaire in assessment of 3000 obstetric-gynecologic patients: the PRIME-MD patient health questionnaire obstetrics-gynecology study. Am J Obstet Gynecol. 2000;183(3):759–69.PubMedCrossRef
21.
Keum BT, Miller MJ, Inkelas KK. Testing the factor structure and measurement invariance of the PHQ-9 across racially diverse U.S. college students. Psychol Assess. 2018;30(8):1096–106.PubMedCrossRef
22.
Patel JS, Oh Y, Rand KL, Wu W, Cyders MA, Kroenke K, et al. Measurement invariance of the patient health questionnaire-9 (PHQ-9) depression screener in U.S. adults across sex, race/ethnicity, and education level: NHANES 2005-2016. Depress Anxiety. 2019;36(9):813–23.PubMedPubMedCentralCrossRef
23.
Burdzovic Andreas J, Brunborg GS. Depressive symptomatology among Norwegian adolescent boys and girls: the patient health Questionnaire-9 (PHQ-9) psychometric properties and correlates. Front Psychol. 2017;8:887.PubMedPubMedCentralCrossRef
24.
Ferrari AJ, Charlson FJ, Norman RE, Patten SB, Freedman G, Murray CJ, Whiteford HA. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med. 2013;10(11):e1001547.PubMedPubMedCentralCrossRef
25.
Dryman MT, Heimberg RG. Emotion regulation in social anxiety and depression: a systematic review of expressive suppression and cognitive reappraisal. Clin Psychol Rev. 2018;65:17–42.PubMedCrossRef
26.
Mallorquí-Bagué N, Vintró-Alcaraz C, Sánchez I, Riesco N, Agüera Z, Granero R, et al. Emotion regulation as a transdiagnostic feature among eating disorders: cross-sectional and longitudinal approach. Eur Eat Disord Rev. 2018;26(1):53–61.PubMedCrossRef
27.
Prefit AB, Cândea DM, Szentagotai-Tătar A. Emotion regulation across eating pathology: a meta-analysis. Appetite. 2019;143:104438.PubMedCrossRef
28.
Sloan E, Hall K, Moulding R, Bryce S, Mildred H, Staiger PK. Emotion regulation as a transdiagnostic treatment construct across anxiety, depression, substance, eating and borderline personality disorders: a systematic review. Clin Psychol Rev. 2017;57:141–63.PubMedCrossRef
29.
Fowler JC, Charak R, Elhai JD, Allen JG, Frueh BC, Oldham JM. Construct validity and factor structure of the difficulties in emotion regulation scale among adults with severe mental illness. J Psychiatr Res. 2014;58:175–80.PubMedCrossRef
30.
Rø Ø, Reas DL, Stedal K. Eating disorder examination questionnaire (EDE-Q) in Norwegian adults: discrimination between female controls and eating disorder patients. Eur Eat Disord Rev. 2015;23(5):408–12.PubMedCrossRef
31.
Thornton LM, Munn-Chernoff MA, Baker JH, Juréus A, Parker R, Henders AK, et al. The anorexia nervosa genetics initiative (ANGI): overview and methods. Contemporary Clin Trials. 2018;74:61–9.CrossRef
32.
Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7.CrossRefPubMed
33.
Johnson SU, Ulvenes PG, Øktedalen T, Hoffart A. Psychometric properties of the general anxiety disorder 7-item (GAD-7) scale in a heterogeneous psychiatric sample. Front Psychol. 2019;10:1713.PubMedPubMedCentralCrossRef
34.
Byrne SM, Allen KL, Lampard AM, Dove ER, Fursland A. The factor structure of the eating disorder examination in clinical and community samples. Int J Eat Disord. 2010;43(3):260–5.PubMed
35.
Grilo CM, Reas DL, Hopwood CJ, Crosby RD. Factor structure and construct validity of the eating disorder examination-questionnaire in college students: further support for a modified brief version. Int J Eat Disorders. 2015;48(3):284–9.CrossRef
36.
White HJ, Haycraft E, Goodwin H, Meyer C. Eating disorder examination questionnaire: factor structure for adolescent girls and boys. Int J Eat Disord. 2014;47(1):99–104.PubMedCrossRef
37.
Kaufman EA, Xia M, Fosco G, Yaptangco M, Skidmore CR, Crowell SE. The difficulties in emotion regulation scale short form (DERS-SF): validation and replication in adolescent and adult samples. J Psychopathol Behav Assess. 2016;38(3):443–55.CrossRef
38.
Cohen J. Statistical Power Analysis for the Behavioural Sciences. 2 ed. Hillsdale,NJ:1988; 1988.
39.
Woods CM, Oltmanns TF, Turkheimer E. Illustration of MIMIC-model DIF testing with the schedule for nonadaptive and adaptive personality. J Psychopathol Behav Assess. 2009;31(4):320.PubMedPubMedCentralCrossRef
40.
Brown TA. Confirmatory factor analysis for applied research: Guilford publications; 2015.
41.
Hu L, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Model Multidiscip J. 1999;6(1):1–55.CrossRef
42.
Schumacker RE, Lomax RG. A beginner's guide to structural equation modeling: psychology press; 2004.CrossRef
43.
Browne MW, Cudeck R. Alternative ways of assessing model fit. In: Bollen KA, Long JS, editors. Testing structural equation models. Beverly Hills: Sage; 1993. p. 136–62.
44.
González-Blanch C, Medrano LA, Muñoz-Navarro R, Ruíz-Rodríguez P, Moriana JA, Limonero JT, et al. Factor structure and measurement invariance across various demographic groups and over time for the PHQ-9 in primary care patients in Spain. PLoS One. 2018;13(2):e0193356.PubMedPubMedCentralCrossRef
45.
Shin C, Ko YH, An H, Yoon HK, Han C. Normative data and psychometric properties of the patient health Questionnaire-9 in a nationally representative Korean population. BMC Psychiatry. 2020;20(1):194.PubMedPubMedCentralCrossRef
46.
Kocalevent RD, Hinz A, Brahler E. Standardization of the depression screener patient health questionnaire (PHQ-9) in the general population. Gen Hosp Psychiatry. 2013;35(5):551–5.PubMedCrossRef
47.
Hayes NA, Welty LJ, Slesinger N, Washburn JJ. Moderators of treatment outcomes in a partial hospitalization and intensive outpatient program for eating disorders. Eat Disord. 2019;27(3):305–20.PubMedCrossRef
48.
Rose C, Waller G. Cognitive-behavioral therapy for eating disorders in primary care settings: does it work, and does a greater dose make it more effective? Int J Eat Disord. 2017;50(12):1350–5.PubMedCrossRef
Metadata
Title
Psychometric properties of the Norwegian version of the Patient Health Questionnaire-9 (PHQ-9) in a large female sample of adults with and without eating disorders
Authors
Line Wisting
Sverre Urnes Johnson
Cynthia M. Bulik
Ole A. Andreassen
Øyvind Rø
Lasse Bang
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2021
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-020-03013-0

Other articles of this Issue 1/2021

BMC Psychiatry 1/2021 Go to the issue

Research

Effect of cognitive behavioral therapy-based counseling on perceived stress in pregnant women with history of primary infertility: a controlled randomized clinical trial

Research

Psychological distress among Ethiopian migrant returnees who were in quarantine in the context of COVID-19: institution-based cross-sectional study

Research article

Experiences and management of physician psychological symptoms during infectious disease outbreaks: a rapid review

Research

Patient experience of lasting negative effects of psychological interventions for anxiety and depression in secondary mental health care services: a national cross-sectional study

Research

A sequence analysis of hospitalization patterns and service utilization in patients with major psychiatric disorders in China

Research

Smoking among inpatients in treatment for substance use disorders: prevalence and effect on mental health and quality of life